# Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire

> **NCT00517621** · PHASE2 · COMPLETED · sponsor: **ARCAGY/ GINECO GROUP** · enrollment: 100 (estimated)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Neoplasms

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** EPO

## Key facts

- **NCT ID:** NCT00517621
- **Lead sponsor:** ARCAGY/ GINECO GROUP
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2010-09
- **Final completion:** 2010-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517621, "Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00517621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*